Loading company…
Riskpilot
← Back to search
Sign in
Get full access
RESYM AS
AS
Active
Org 960246624
Neuberggata 1A, 0367 Oslo
Production of electricity from renewable sources · NACE 3512
Est. 1990
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-47% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -382
+88% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -5K
-47%
Net profit
NOK -382
+88%
Total assets
NOK 475K
+0%
Equity
NOK 475K
+0%
Employees
0
—
Company information
Legal name
RESYM AS
Org number
960246624
Legal form
Aksjeselskap
NACE code
3512 · Production of electricity from renewable sources
Founded
28. desember 1990
Share capital
NOK 102 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Contact
Address
Neuberggata 1A, 0367 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Production of electricity from renewable sources
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−2
−2
−3
−3
−5
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−2
−2
−3
−3
−5
Net financials
0
−0
0
−0
4
Profit before tax
−2
−2
−3
−3
−0
Tax
−0
−0
−0
−0
−0
Net profit
−2
−2
−3
−3
−0
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
484
481
478
475
475
Equity
483
481
478
475
475
Long-term debt
0
0
0
0
0
Short-term debt
1
0
0
0
0
Total debt
1
0
0
0
0
Financial ratios
5-year trend
EBITDA margin
-462400.0%
This company
15.8%
Market median
-2926682% vs market
2020
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2020
2024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
2020
2024
Net profit margin
-38200.0%
This company
8.1%
Market median
-471705% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PN
Per-Erik Nordal
Deputy Member
Deputy Member
2008
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
EH
Espen Hygen Daae
Chairman
2008
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Biotech Invest As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Biotech Invest As
RESYM AS
(this company)
Board network connections
Board members of RESYM AS also hold positions in
0
other companies.
Person
Role here
Other companies
Per-Erik Nordal
Deputy Member
0 companies
Espen Hygen Daae
Chairman
0 companies